Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
SMLR | US
0.84
3.48%
Healthcare
Medical Devices
30/06/2024
04/10/2024
24.99
24.56
25.10
24.20
Semler Scientific Inc. provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition. It also offers Insulin Insights a software program that is used by a healthcare provider to optimize outpatient insulin dosing. The company's products serve cardiologists internists nephrologists endocrinologists podiatrists and family practitioners as well as healthcare insurance plans integrated delivery networks independent physician groups and companies contracting with the healthcare industry such as risk assessment groups long-term care or remote patient monitoring organizations. It offers its products through salespersons and distributors. The company was incorporated in 2007 and is headquartered in Santa Clara California.
View LessLow Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
Strong Operating Margin (> 25%)
High Short-term Volatility
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
Declining Revenue (< 0%)
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
64.8%1 month
50.6%3 months
59.9%6 months
81.0%11.71
-
2.12
0.00
0.00
6.78
2.48
-
22.23M
174.74M
174.74M
-
36.99
-99.80
-22.30
22.02
6.12
12.51
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
3.33
Range1M
4.94
Range3M
15.01
Rel. volume
0.99
Price X volume
3.07M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Accuray Incorporated | ARAY | Medical Devices | 1.91 | 191.51M | 7.91% | n/a | 467.45% |
CVRx Inc. | CVRX | Medical Devices | 8.78 | 191.28M | 1.04% | n/a | 55.37% |
Electromed Inc | ELMD | Medical Devices | 21.66 | 187.12M | -1.32% | 35.00 | 0.20% |
Nevro Corp | NVRO | Medical Devices | 4.97 | 185.30M | -3.68% | n/a | 88.48% |
Stereotaxis Inc | STXS | Medical Instruments & Supplies | 2.04 | 172.70M | 4.62% | n/a | 31.50% |
BRAINSWAY LTD | BWAY | Medical Devices | 9.5 | 158.44M | 5.56% | 403.50 | 10.16% |
InfuSystem Holdings Inc | INFU | Medical Instruments & Supplies | 6.75 | 143.88M | 2.58% | 675.00 | 73.21% |
Lakeland Industries Inc | LAKE | Medical Instruments & Supplies | 19.25 | 142.38M | -1.43% | 77.62 | 35.09% |
TriSalus Life Sciences Inc. | TLSI | Medical Devices | 4.55 | 133.37M | 2.25% | 0.09 | -94.26% |
Akoya BioSciences Inc. Common Stock | AKYA | Medical Instruments & Supplies | 2.78 | 130.39M | 3.73% | n/a | 380.68% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
STHO | STHO | Real Estate Services | 13 | 173.15M | -3.20% | n/a | 59.21% |
Douglas Elliman Inc. | DOUG | Real Estate Services | 1.66 | 152.44M | -7.26% | n/a | 62.82% |
Comstock Holding Companies Inc | CHCI | Real Estate Services | 11.7 | 115.38M | 14.71% | 11.75 | 17.12% |
Comstock Mining Inc | LODE | Real Estate Services | 0.521 | 107.66M | 21.16% | 6.09 | 14.37% |
OPAD | OPAD | Real Estate Services | 3.39 | 92.73M | -5.31% | n/a | 406.11% |
Kewaunee Scientific Corporation | KEQU | Building Products & Equipment | 31.64 | 90.86M | -0.32% | 5.47 | 19.82% |
Saga Communications Inc | SGA | Broadcasting - Radio | 14 | 87.66M | -1.27% | 14.62 | 7.10% |
Urban One Inc | UONEK | Broadcasting - Radio | 1.02 | 57.65M | -4.67% | n/a | 268.43% |
Fathom Holdings Inc | FTHM | Real Estate Services | 2.7 | 56.72M | 3.45% | n/a | 36.20% |
The InterGroup Corporation | INTG | Real Estate Services | 16.4 | 35.87M | 7.75% | n/a | -257.98% |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | 6.78 | 45.99 | Cheaper |
Ent. to Revenue | 2.48 | 13.20 | Cheaper |
PE Ratio | 11.71 | 29.98 | Cheaper |
Price to Book | 2.12 | 6.06 | Cheaper |
Dividend Yield | - | 1.65 | - |
Std. Deviation (3M) | 59.91 | 66.08 | Par |
Debt to Equity | 0.00 | 0.83 | Cheaper |
Debt to Assets | 0.00 | 0.28 | Cheaper |
Market Cap | 174.74M | 9.42B | Emerging |